Novel endoscopic technologies in the treatment of benign prostatic hyperplasia


Cite item

Full Text

Abstract

References

  1. Гориловский Л. М. Оперативное лечение урологических заболеваний в пожилом и старческом возрасте: Дис. ... д-ра мед. наук. М.; 1984.
  2. Гориловский Л. М. Очерки гериатрической урологии. М: 1993.
  3. Мартов А. Г., Кильчуков 3. И. Интерстициальная лазерная коагуляция у больных доброкачественной гиперплазией простаты. Урол. и нефрол. 1996; 5: 24-27.
  4. Мартов А. Г., Лопаткин Н. А. Практическое руководство по трансуретральной эндоскопической электрохирургии доброкачественной гиперплазии предстательной железы. М.: Триада X; 1997.
  5. Мартов А. Г. Трансуретральная резекция (ТУР) в лечении доброкачественной гиперплазии предстательной железы. В кн.: Лопаткин Н. А. (ред.) Доброкачественная гиперплазия предстательной железы. М.; 1999. 193-209.
  6. Мартов А. Г., Камалов А. А. Малоинвазивные эндоскопические методы лечения доброкачественной гиперплазии предстательной железы. Там же. 164-175.
  7. Мартов А. Г., Меринов Д. С. Трансуретральная роторезекция - новый метод лечения доброкачественной гиперплазии предстательной железы. Урология. 2000; 6: 6-10.
  8. Портной А. С. Хирургическое лечение аденомы и рака предстательной железы. М.; 1989.
  9. Разумов С. В. Применение трансуретральной эндоскопической электровапоризации в лечении больных доброкачественной гиперплазией предстательной железы: Дис. ... канд. мед. наук. М.; 2000.
  10. Симонов В. Я. Трансуретральная электрорезекция при заболеваниях предстательной железы, мочевого пузыря и уретры: Дис. ... д-ра мед. наук. М.; 1982.
  11. Трапезникова М. Ф., Базаев В. В., Морозов А. П. Лечение ДГПЖ неодимовым YAG-лазером. В кн.: Материалы Международного симпозиума новых лазерных технологий. 1995. 125-127.
  12. Anjum M. I. Long-term clinical results and quality of life after insertion of self-expending flexible endourethral prothesis. Br. J. Urol. 1997; 80: 885-888.
  13. Anson K., Nawrocki J., Buckley J. et al. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995; 46: 305- 310.
  14. Beerlage H. P., Francisca E. A. E., d'Ancona F. С. H. et al. Urolase versus Ultraline fibers in laser prostatectomy: 3-year followup of a prospective randomized study. J. Endourol. 1999; 12: 575-580.
  15. Blandy J. P., Notley R. G. S. The instruments. In: Blandy J., Notley R. The instruments. Oxford; Butterworth-Heinemann Ltd; 1993. 10-27.
  16. Blomqvist P., Ekbom A., Carlsson P. et al. Benign prostatic hyperplasia in Sweden 1987-1994: Changing patterns of treatment, changing patterns of costs. Urology 1997; 50: 214-219.
  17. Borkowski M., Neuhaus L., Farm G. Transurethrale Prostatedenomvaporisation; EVAP. Urologe 1996; 36: 47-53.
  18. Bruskewitz R. C., Larsen E. H., Madsen P. O., Dorflinger T. 3year follow-up of urinary symptoms after transurethral resection of the prostate. J. Urol. (Baltimore) 1986; 136: 613-615.
  19. Chilton C. P., Morgan R. J., England H. R. et al. A critical evaluation of the results of transurethral resection of the prostate. Br. J. Urol. 1978; 50: 542-546.
  20. Chiou R. K. et al. Long-term outcome of prostatic stent treatment for BPH. Urology 1996; 48: 589-593.
  21. Chiu A. W. et al. Stone incrustation: A relevant complication of the intraprostatic spiral. Eur. Urol. 1991; 19: 304-307.
  22. Costello A. J., Bowsher W. G., Bolton D. M. et al. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br. J. Urol. 1992; 69: 603-608.
  23. Costello A. J., Lusaya D. G. Noncontact sidefiring ablation of the prostate. J. Endourol. 1995; 2 (9): 107-111.
  24. Cowles R. S., Kabalin J. N., Childs S. et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995; 46: 155-160.
  25. De la Rosette J. J. M. С. H, Froeling F. M. J. A., Alivizatos G., Debruyne F. M. J. Laser ablation of the prostate: experience with an ultrasound guided technique and a procedure under direct vision. Eur. Urol. 1994; 25: 19-24.
  26. De la Rosette J. J. M. С. H., te Slaa E., de Wild M. J., Debruene F. M. Experience with the Ultraline and Urolase laser fibers: is there any difference? Wld J. Urol. 1995; 13: 98-103.
  27. De la Rosette J. J. M. С. H., D'Ancona F. С. H., Debruyne F. M. J. Current status of thermotherapy of the prostate. J. Urol. (Baltimore) 1997; 157: 430-438.
  28. De la Rosette J. J. M. С. H, Muschter R., Lopez M. A., Gillat D. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia. Br. J. Urol. 1997; 80: 433-438.
  29. DeSautel M. G., Burney T. L., Diaz P. A. et al. Outcome of VaporTrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria. Urology 1998; 51: 1013-1017.
  30. Devonec M. et al. Temporary urethral stenting after high energy transurethral microwave thermotherapy of the prostate. Wld J. Urol. 1998; 16: 120-123.
  31. Dineen M. K., Brown В. Т., Cantwell A. L. et al. Outpatient transurethral resection of the prostate with vaporization assistance: a two year experience in a free standing ambulatory surgery center. J. Urol. (Baltimore) 1997; 157 (suppl.): 314.
  32. DiTrolio J. V. AMS 001 Study, 2001.
  33. Dixon С. М. Lasers for the treatment of benign prostatic hyperplasia. Urol. Clin. N. Am. 1995; 22: 413-422.
  34. Djavan В., Madersbacher S., Klingler C., Marberger M. Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostatectomy predictable? J. Urol. (Baltimore) 1997; 158: 1829-1833.
  35. Djavan B. et al. A novel intraprostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with BPH. Ibid. 1999; 161: 144-151.
  36. Doll H. A., Black N. A., McPherson K. et al. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. Ibid. 1992; 147: 1566-1573.
  37. Dorflinger Т., Jensen F. S., Krarup Т., Walter S. Transurethral prostatectomy compared with incision of the prostate in the treatment of prostatism caused by small benign prostate glands. Scand. J. Urol. Nephrol. 1992; 26: 333-338.
  38. Effort P., Ackermann R. Surgical prostatectomy. In: Chicholm G. D., ed. Handbook on BPH. New York: Raven Press; 1994. 95-114.
  39. Fabian K. M. Der intraprostatishe "Partielle Katheter" (urologische Spirale). Urologe A 1980; 19: 236-238.
  40. Fastenmeier K., Flachenecker G. S. High frequency technology: applications and hazards. In: Mauermayer W., Fastenmeier K., Flachenecker G. et al. High frequency technology: applications and hazards. Berlin: Springer-Verlag; 1983. 47-60.
  41. Faul P., Farin G., Reich O., Steude U. The 'Band electrode': first experiences with a novel TURP procedure to improve hemostatis. Eur. Urol. 1996; 30: 403-408.
  42. Flam Т., Spitzenfail E., Gout E. et al. TULIP: transurethral ultrasound-guided laser-induced prostatectomy. J. Urol. (Paris) 1993; 99: 61-66.
  43. Floratos D. L., de la Rosette J. J. M. С. H. Lasers in urology. Br. J. Urol. Int. 1999; 84: 204-211.
  44. Garrawey W. M., Collins G. L., Lee R. G. High prevalence of BPH in the community. Lancet 1991; 338: 469-471.
  45. Gilling P. G., Gass С. В. et al. The evolution of the use of holmium laser for the treatment of benign prostatic hyperplasia. SPIE Proc. 1997; 2970: 448-451.
  46. Gilling P. G., Fraundorfer M. R. Holmium laser prostatectomy: a technique in evolution. Curr. Opin. Urol. 1998; 8: 11 - 15.
  47. Glynn R. J., Campion E. W. The development of BPH among volunteers in the normative aging study. Am. J. Epidemiol. 1985; 121: 78-90.
  48. Goddard D. W. S. Principles of electrosurgery. In: Glenn J. Principles of electrosurgery, urologic surgery. Philadelphia: JB Lippincott; 1983. 879-890.
  49. Gallucci M., Puppo P., Perachino M. et al. Transurethral electrovaporization of the prostate vs. transurethral resection: Results of a multicentric, randomized clinical study on 150 patients. Eur. Urol. 1998; 33: 359-364.
  50. Guazzoni G. et al. A modified prostatic UroLume Wallstent for healthy patients with symptomatic BPH: A European multicentric study. Urology 1994; 44: 364-370.
  51. Hahn R. G. Ethanol monitoring of extravascular absorption of irrigating fluid. Br. J. Urol. 1993; 72: 766-769.
  52. Hammadeh M. Y., Fowlis G. A., Singh M. et al. Transurethral electovaporization of the prostate a possible alternative to transurethral resection: a one year follow-up of a prospective randomized tial. Br. J. Urol. 1997; 79 (suppl. 4); 62.
  53. Hammadeh M., Madaan S., Singh M. et al. Transurethral electro-vaporization of the prostate, a possible alternative to standard TURP. Three years follow-up of a prospectively randomised trial. J. Urol. (Baltimore) 1999; 161 (suppl.): 391.
  54. Harrison N. W. Prostatic stenting for outflow obstruction. Br. J. Urol. 1990; 163: 192-196.
  55. Health care financing administration. BESS Data. Washington; 1994.
  56. Hellstrom P., Lukkarinn O., Kontturi M. Bladder neck incision or transurethral electroresection for the treatment of urinary obstruction caused by a small benign prostate. Scand. J. Urol. Nephrol. 1986; 20: 187-192.
  57. HofstetterA. et al. Treatment of prostatic tumors with itnerstitial thermocoagulation with neodymium-YAG (a new treatment in minimally invasive surgery). Arch. Esp. Urol. 1993; 46 (6): 317-319.
  58. Holtgrewe H. L., Valk W. L. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2015 cases. J. Urol. (Baltimore) 1962; 87: 450-454.
  59. Holtgrewe H. L. Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia. Urology 1998; 51: 1-7.
  60. Horninger W., Unterlechner H., Strasser H. Transurethral prostatectomy: mortality and morbidity. Prostate 1996; 28: 195- 200.
  61. Hulka J. F., Reich H. eds. Textbook of laparoscopy. 2-nd ed. Philadelphia; Saunders; 1994. 23-46.
  62. Isaacs J. Т., Coffey D. S. Etiology and disease process of BPH. Prostate 1989; 3: 33-50.
  63. Jensen K. M. E., Jorgensen J. В., Mogensen P. Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms. Br. J. Urol. 1996; 78: 213-218.
  64. Johnson D. E., Price R. E., Cromeenc D. M. Pathologic changes occurring in the prostate following transurethral laser prostatectomy. Laser Surg. Med. 1992; 12 (3): 254-263.
  65. Jung P., Mattelar P., Wolf J. M. et al. Visual laser ablation of the prostate: efficacy evaluated by urodynamics and compared to TURP. Eur. Urol. 1996; 30: 418-423.
  66. Kabalin J. N., Gill H. S., Bite G., Wolfe V. Comparative study of laser versus electrocautery prostatic resection: 18-month follow-up with complex urodynamic assessment. J. Urol. (Baltimore) 1995; 153: 94-98.
  67. Kabalin J. N., Bite J., Doll S. Neodimium: YAG coagulation prostatectomy: 3 years of experience with 227 patients. Ibid. 1996; 155: 181-185.
  68. Kabalin J. N. Holmium: YAG laserrostatectomy: Results of US pilot study. J. Endourol. 1996; 10: 453-457.
  69. Kabalin J. N. Laser prostatectomy. Curr. Opin. Urol. 1997; 7: 37-43.
  70. Kabalin J. N., Gilling P. J., Fraundofer M. R. Holmium: yttrium-aluminum-garnet laser prostatectomy. Mayo Clin. Proc. 1998; 73: 792-797.
  71. Kandel L. В., Harrison L. H. et al. The laser prostatectomy: Creation of a technique for using the neodymium: YAG laser in the canine model. J. Urol. (Baltimore) 1986; 135: 110A.
  72. Keckstein J. S. Tissue effects of different lasers and electrodiathermy. In: Sutton C, Diamond M. Tissue effects of different lasers and electrodiathermy. Philadelphia: WB Saunders; 1993. 60-70.
  73. Keoghane S. R., Cranston D. W., Lawrence К. С. et al. The Oxford Laser Prostate Trial: a double-blind randomized controlled trial of contact vaporization of the prostate against transurethral resection; preliminary results. Br. J. Urol. 1996; 77: 382-385.
  74. Kirwin T. J. The treatment of prostatic hypertrophy by a new 'shrinkage' method. J. Urol. (Baltimore) 1934; 32: 481.
  75. Kramolowsky E. V., Tucker R. D. The urological application of electrosurgery. Ibid. 1991; 146: 669-674.
  76. Kuntzman R. S., Malek R. S., Barrett D. M. High-power potassium titanyl phosphate laser vaporization prostatectomy. Mayo Clin. Proc. 1998; 73: 798-801.
  77. Larsen T. R., Religo W. M., Collins J. M. et al. Detailed prostatic interstitial thermal mapping during transurethal grooved rollerball electrovaporization and loop electrosurgery for benign prostatic hyperplasia. Urology 1996; 48: 501-507.
  78. Le Due A., Cortesse A., Lottman H. et al. In: Contemporary BPH management. Bologna; 1993. 133-139.
  79. Lee R. C., Gaylor D. C., Bhatt D. et al. Role of cell membrane rupture in the pathogenesis of electrical trauma. J. Surg. Res. 1988; 44: 709-719.
  80. Levy D. A. Transurethral ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model. Urology 1999; 53: 1245-1251.
  81. Lim L. M., Patel A., Ryan T. P. et al. Quantitative assessment of variables that influencew soft-tissue electrovaporization in a fluid environment. Ibid. 1997; 49: 851-856.
  82. Littrup P. J., Lee F., Borlaza G. S. et al. Percutaneous ablation of canine prostate using transurethral ultrasound guidance. Absolute ethanol and Nd: YAG laser. Invest. Radiol. 1988; 23: 734-739.
  83. Large F. J., Nesa S., Wese F. X., Van Cangh P. J. Efficacy of laser prostatectomy at 2 years follow-up. J. Endourol. 1996; 10: 449-451.
  84. Lusaya D. G., Costello A. J. Laser ablation of the prostate. Curr. Opin. Urol. 1995; 13 (2): 143-146.
  85. Madersbacher S., Kratzik C., Szobo N. et al. Treatment of BPH by thermal ablation with transrectal high-intensity focused ultrasound (HIFU). Clinical results. Eur. Urol. 1993; 23 (suppl. 1): 39-43.
  86. Madersbacher S., Susani M., Kratzik C., Marberger M. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J. Urol. (Baltimore) 1994; 152: 1956-1961.
  87. Madersbacher S., Klingler H. C., Schatzl G. et al. Age related urodynamic changes of patients with benign prostatic hyperplasia. Ibid. 1996; 156: 1662-1667.
  88. Madersbacher S., Klingler H. C., Djavan B. et al. Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms? Br. J. Urol. 1997; 80: 72-77.
  89. Madersbacher S., Djavan В., Marberger M. Minimally invasive treatment for benign prostatic hyperplasia. Curr. Opin. Urol. 1998; 8: 17-26.
  90. Madersbacher S., Haidinger G., Temml C., Schmidbauer C. P. The prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men. Eur. Urol. 1998; 34: 136-141.
  91. Madersbacher S., Marberger M. Is transurethral resection of the prostate still justified? Br. J. Urol. Int. 1999; 83: 227-237.
  92. Matben P. Q., Iversen P. A point system for selecting operative candidates. BPH. Berlin; 1983. 763-765.
  93. Matsuoka K., Iida S. Holmium laser resection of the prostate. J. Endourol. 1998; 12: 279-282.
  94. McAllister W. J., Karim O., Plail R. et al. A prospective randomized multicentre trial of transurethral electrovaporization of the prostate against TURP. Preliminary results. Br. J. Urol. 1998; 81 (suppl. 4): 22.
  95. McCarthy J. S. Physics in medicine and biology: encyclopedia. In: McAnish T. Physics in medicine and biology: Encyclopedia. New York: Pergamon Press; 1986. 319-323.
  96. McCollough D. L. Laser prostatectomy: free beam and contact techniques. Curr. Opin. Urol. 1996; 6: 10-13.
  97. Meade W. M., Mcloughlin M. G. Endscopic rollerball electrovaporization of the prostate - the sandwich technique: evaluation of initial efficacy and morbidity in the treatment of benign prostatic obstruction. Br. i. Urol. 1996; 77: 696-700.
  98. Mebust W. K., Holtgrewe H. L., Coickett А. Т. К. et al. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J. Urol. (Baltimore) 1989; 141: 243-247.
  99. Melchior J., Valk W. L., Foret J. D., Mebust W. К. Transurethral prostatectomy: computerized analysis of 2,223 consecutive case. Ibid. 1974; 112: 634-642.
  100. Michel M., Kohrmann K., Weber A. et al. Rotoresect: New technique for resection of the prostate: experimental phase. J. Endourol. 1996; 10 (5): 473-478.
  101. Michel M., Kohrmann K., Weber A. et al. Comparison of laservaporisation, electro-vaporisation and modified electroloop-resection. Br. J. Urol. 1996; 78: 643.
  102. Michel M. S., Kohrmann K. U., Weber A. et al. Standardized comparison of laser-vaporization, electro-vaporization and modified electroloop-resection. J. Urol. (Baltimore) 1997; 157 (suppl.): 436.
  103. Michel M., Keller H., Frede T. et al. The rotoresect system for bloodless transurethral resection of the prostate. Advantages in clinical application by technical modifications. J. Endourol. 1999; 13 (suppl. 1): A 31, FP2-15.
  104. Milroy E. J. A new treatment for urethral strictures. Lancet 1988; 25: 1424-1427.
  105. MitchillJ. P., Lumb G. N., Dobbie A. K. Handbook of surgical dieathermy. Bristol: John Wright and Sons Ltd; 1978. 1-121.
  106. Mueller E. J. Contact laser vaporization of the prostate: one surgeon's experience with 50 consecutive cases. Tech. Urol. 1996; 2: 136-141.
  107. Munro M. G. S. Energy sources for operative laparoscopy. In: Gomel V., Taylor P. Energy sources for operative laparoscopy. New York: Mosby; 1995. 26-56.
  108. Muschter R., Zellner M., Hessel S., Hofstetter A. Lasers and bening prostatic hyperplasia - experimental and clinical results to compare different application systems. J. Urol. (Baltimore) 1994; 151: 230A.
  109. Muschter R. Interstitital laser therapy. Curr. Opin. Urol. 1996; 6: 33-38.
  110. Narayan P., Tewary A. Electrovaporization of the prostate: Principles, technique and results. In: Smith J. A. Techniques for ablation of benign and malignant prostate tissue. New York; 1996. 206-231.
  111. Narayan P., Tewari A., Coker B. et al. Factors affecting size and configuration of electrovaporization lesions in the prostate. Urology 1996; 47: 679-688.
  112. Nielsen К. К. et al. Neurourol. Urodin. 1994; 13: 13-19.
  113. Nissenkorn J. A new self-retaining intra urethral device. An alternative to an indwelling catheter in patients with urinary retention due to infravesical obstruction. Br. J. Urol. 1990; 65: 197-200.
  114. Nissenkorn I. The intraurethral catheter - 3 years of experience. In: Congr. Eur. Assoc. Urol. 1992. abstr. 233.
  115. Nobuyuki Goya: Ethanol injection therapy of the prostate for benign prostatic hyperplasia: Prliminary report on application of a new technique. J. Urol. (Baltimore) 1999; 162: 383-386.
  116. Nordling J. et al. The intraprostatic spiral. Ibid. 1989; 142: 756- 758.
  117. Nordling J. et al. The intraprostatic spiral: clinical results in 150 consecutive patients. Ibid. 1992; 147: 645-647.
  118. Odetl R. S. Electrosurgery. In: Sutton C, Diamond M. Electrosurgery. Philadelphia: WB Saunders; 1993. 51-59.
  119. Orandi A. J. Urol. (Baltimore) 1973; 110: 229-233.
  120. Orandi A. Transurethral incision of prostate compared with transurethral resection of prostate in 132 matching cases. Ibid. 1987; 138: 810-815.
  121. Patel A., Fuchs G. J., Gutierrez-Aceves J. A pilot study of energy utilization patterns during different transurethral electrosurgical treatments of the prostate. Urology 1997; 50: 138-141.
  122. Patel A., Fuchs G. J., Gutierrez-Aceves J. et al. Prostate heating patterns comparing electrosurgical transurethral resection and vaporization: a prospective randomized study, i. Urol. (Baltimore) 1997; 157: 169-172.
  123. Patel A., Fuchs G. J., Gutierrez-Aceves J. et al. A prospective randomized double blind study of transurethral resection (TURP) vs. electro-vaporization (TUEVAP) of the prostate. Br. J. Urol. 1997; 80 (suppl. 2): 190.
  124. Patel A., Fuchs G. J., Gutierrez-Aceves J. et al. Completeness and efficiency of prostate tissue removal: loop resection compared with a new operative technique of transurethral resection of the prostate. Ibid. 1999; 84: 43-49.
  125. Patel A., Fuchs G. J. Transurethral electrovaporization and vapour-resection of the prostate: an appraisal of possible electrosurgical altrnatives to regular loop resection. Br. J. Urol. Int. 2000; 85: 202-210.
  126. Perlmutter A. P., Muschter R., Razvi H. A. Electrosurgical vaporization of the prostate in the canine model. Urology 1995; 46: 518-520.
  127. Perlmutter A. P. Advances in electrosurgical techniques. Curr. Opin. Urol. 1997; 7: 21-24.
  128. Porru D., Scarpa R. M., Campus G. et al. Transurethral electrovaporization of the prostate in benign prostatic hyperplasia. Evaluation of results using different urodynamic parameters. Scand. J. Urol. Nephrol. 1998; 32: 123-126.
  129. Reis R. R., Cologna A. J., Suaid H. J. et al. Interstitial thermotherapy in men undergoing electrovaporization: is it safe? J. Urol. (Baltimore) 1996; 155 (suppl.): 707A.
  130. Reis R. R., Cologna A. J., Suaid H. J. et al. Electrovaporization of the prostate (VAP): a comparison of roller electrode configurations for resecting prostate tissue. Ibid. 406A.
  131. Reynard J., Abrams P. Eur. Urol. Update Ser. 1992; 1: 90-95.
  132. Riehmann M., Knes J. M., Heisey D. et al. Transurethral resection versus incision of the prostate; a randomized, prospective study. Urology 1995; 45: 768-775.
  133. Rollema H. J., van Mastrigt R. J. Urol. (Baltimore) 1992; 142: 111-117.
  134. Roos N. P., Wennberg J. E., Malenka D. J. et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N. Engl. J. Med. 1989; 320: 1120-1124.
  135. Saporta L., Aridogan I. A., Erlich N., Yachia D. Objective and subjective comparison of transurethral resection, transurethral incision and balloon dilatation of the prostate. Eur. Urol. 1996; 29: 439-445.
  136. Sassine A. W. Intraurethral catheter in high-risk patients with urinary retention: 3 years of experience. Ibid. 1994; 25: 131 - 134.
  137. Schaltz G., Madersbacher S., Lang Т., Marberger M. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatmnt alternatives. J. Urol. (Baltimore) 1997; 158: 105-111.
  138. Schou J., Holm-Christensen N. E., Nolsoe С. et al. Prostatectomy and impotence. Can temperature variations around the prostate during TURP explain post-prostatectomy impotence? Scand. J. Urol. Nephrol. 1996; Suppl. 179: 123-127.
  139. Shokeir A. A., Al-Sisi M., Farage M. A. et al. Transurethral prostatectomy: a prospective randomized study of conventional resection and electrovaporization in benign prostatic hyperplasia. Br. J. Urol. 1997; 80: 570-576.
  140. Sonn D. J., Badlani G. H. Contact laser vaporization of the prostate: sidefiring technique. J. Endourol. 1995; 9 (2): 113- 116.
  141. Soonawalla P. F., Pardanani D. S. Transurethral incision versus transurethral resection of the prostate: A subjective and objective analysis. Br. J. Urol. 1992; 70: 174-177.
  142. Sutton С. F. G., Macdonald R., Magos A. L. et al. Endometrial resection. In: Lewis В., Magos A. Endometrial resection. New York: Churchill Livingstone; 1993. 91-104.
  143. Те A. E., Kaplan S. A. TVEVP. The year in review. Curr. Opin. Urol. 1996; 6: 2-9.
  144. Tewari A., Narayan P. Electrovaporization of the prostate. Br. J. Urol. 1996; 78: 667-676.
  145. Cockett A. et al., eds. The International consultation on BPH. Proceedings. - Paris; 1991.
  146. Cockett A. et al., eds. The International consultation on BPH. Proceedings. - Monaco; 1995.
  147. Thomas A. W., Abrams P. Patients selection: the value of pressure-flow studies. Curr. Opin. Urol. 1998; 8: 5-9.
  148. Thomas P. J. The Prostakath stent: four year experience. Br. J. Urol. 1993; 71: 430-432.
  149. Traxer O. A new prostatic stent for the treatment of BPH in high-risk patients. Eur. Urol. 2000; 38: 272-278.
  150. Valleylab: Force 2: Instruction Manual and SubForce 2: Instruction Manual Boulder, CO, Valleylab Inc; 1985; 7.1-7.11.
  151. Valleylab: Force 30, Force 40: Instruction Manual and SubForce 30, Force 40: Instruction Manual. Boulder, CO < Valleylab Inc; 1993; 7.1-7.11.
  152. Wasson J. H., Reda D. J., Bruskewilz R. С. et al. Vetrans affairs cooperative study group on transurthral resection of the prostate. N. Engl. J. Med. 1995; 322: 75-79.
  153. Watson R. A. Transurethral ethanol ablation of the prostate. J. Urol. (Baltimore) 1999; 161 (4): 304.
  154. Williams G. etal. Use of stents for treating obstruction of urinary outflow in patients unfit for surgery. Br. Med. J. 1989; 298: 1429.
  155. Zvara P. Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection. Urology 1999; 54: 411-415.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies